Kodiak Sciences stock hits 52-week high at $45.73
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kodiak Sciences Inc (KOD)
Kodiak Sciences Inc stock price live, this page displays NASDAQ KOD stock exchange data. View the KOD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Kodiak Sciences Inc real time stock price chart below.
What Is the Kodiak Sciences Inc Stock Price Today?
The Kodiak Sciences Inc stock price today is 41.980.
What Is the Stock Symbol for Kodiak Sciences Inc?
The stock ticker symbol for Kodiak Sciences Inc is KOD.
Is KOD the Same as $KOD?
$KOD is a common way to refer to the Kodiak Sciences Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Kodiak Sciences Inc Trade On?
Kodiak Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Kodiak Sciences Inc a Good Stock to Buy?
Determining whether Kodiak Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Kodiak Sciences Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KOD quote. (ISIN: US50015M1099)
What Is the Kodiak Sciences Inc Stock Price Today?
The Kodiak Sciences Inc stock price today is 41.980.
What Is the Stock Symbol for Kodiak Sciences Inc?
The stock ticker symbol for Kodiak Sciences Inc is KOD.
Is KOD the Same as $KOD?
$KOD is a common way to refer to the Kodiak Sciences Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Kodiak Sciences Inc Trade On?
Kodiak Sciences Inc is listed and trades on the NASDAQ stock exchange.
Is Kodiak Sciences Inc a Good Stock to Buy?
Determining whether Kodiak Sciences Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Kodiak Sciences Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the KOD quote. (ISIN: US50015M1099)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.625
45.500
52 wk Range
2.340
46.670
KOD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.62545.500
52 wk Range
2.34046.670
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockKOD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
56.333
Upside
+34.19%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Kodiak Sciences CFO Borgeson sells $1.2m in shares
- Investing.com
- Kodiak Sciences stock hits 52-week high at $45.73
- Investing.com
- Kodiak Sciences CFO Borgeson sells $1.2m in shares
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company’s preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Kodiak Sciences Inc SWOT Analysis
Market Dynamics | Uncover Kodiak's position in the competitive eye disease treatment market, where success hinges on innovative therapies and the ability to differentiate from established players. |
Financial Landscape | Analyst projections reveal Kodiak's financial hurdles, with EPS forecasts of -$4.08 for FY2025. Price targets range from $3.00 to $4.00, reflecting market uncertainties. |
Pipeline Potential | Delve into Kodiak's promising pipeline, including KSI-101, tarcocimab, and KSI-501, with key trial results expected between 2025 and 2026, potentially reshaping the company's future. |
Kodiak's Crossroads | Explore Kodiak Sciences' pivotal moment as it navigates challenges in eye disease drug development, with its Kodiak 2.0 strategy at the forefront of potential breakthroughs. |
Compare KOD to Peers and Sector
Metrics to compare | KOD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKODPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.3x | −4.3x | −0.5x | |
PEG Ratio | 0.42 | 0.03 | 0.00 | |
Price / Book | 16.5x | 4.0x | 2.6x | |
Price / LTM Sales | - | 38.6x | 3.2x | |
Upside (Analyst Target) | 30.9% | 154.0% | 45.7% | |
Fair Value Upside | Unlock | 2.6% | 4.8% | Unlock |
Analyst Ratings
6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 56.333
(+34.19% Upside)
Earnings
Latest Release
Mar 31, 2026
EPS / Forecast
-1.04 / -1.01
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Is the Kodiak Sciences (KOD) Stock Price Today?
The Kodiak Sciences stock price today is 41.980 USD.
What Stock Exchange Does Kodiak Sciences Trade On?
Kodiak Sciences is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Kodiak Sciences?
The stock symbol for Kodiak Sciences is "KOD."
What Is the Kodiak Sciences Market Cap?
As of today, Kodiak Sciences market cap is 2.590B USD.
What Is Kodiak Sciences's Earnings Per Share (TTM)?
The Kodiak Sciences EPS (TTM) is -4.322.
When Is the Next Kodiak Sciences Earnings Date?
Kodiak Sciences will release its next earnings report on May 20, 2026.
From a Technical Analysis Perspective, Is KOD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Kodiak Sciences Stock Split?
Kodiak Sciences has split 0 times.
How Many Employees Does Kodiak Sciences Have?
Kodiak Sciences has 124 employees.
What is the current trading status of Kodiak Sciences (KOD)?
As of Apr 16, 2026, Kodiak Sciences (KOD) is trading at a price of 41.980 USD, with a previous close of 45.070 USD. The stock has fluctuated within a day range of 41.625 USD to 45.500 USD, while its 52-week range spans from 2.340 USD to 46.670 USD.
What Is Kodiak Sciences (KOD) Price Target According to Analysts?
The average 12-month price target for Kodiak Sciences is 56.333 USD, with a high estimate of 80 USD and a low estimate of 14 USD. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +34.19% Upside potential.
What Is the KOD Premarket Price?
KOD's last pre-market stock price is 45.200 USD. The pre-market share volume is 4,270.000, and the stock has decreased by 0.130, or 0.290%.
What Is the KOD After Hours Price?
KOD's last after hours stock price is 42.000 USD, the stock has decreased by 0.020, or 0.050%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.